STJ  St. Jude Medical Inc.

Exchange

NYSE

Sector

Health Care

Industry

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market Cap.

18.922B

Vuru Grade

63.93/100

Current Price

$66.18
+0.57 (+0.87%)

Growth Price

$39.38
Overvalued by 40.49%

Stability Price

$20.40
Overvalued by 69.18%

Company Metrics

  • 21.67 P/E
  • 3.35 P/S
  • 4.57 P/B
  • 3.027 EPS
  • 13.07% Cash ROIC
  • 0.99 Cash Ratio
  • 1.06 / 1.62 % Dividend
  • 1.93M Avg. Vol.
  • 285.92M Shares
  • 18.922B Market Cap.

Company Description

St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. It operates in four segments: Cardiac Rhythm Management, Cardiovascular, Atrial Fibrillation, and Neuromodulation. The Cardiac Rhythm Management segment offers products for cardiac arrhythmias, or irregular heart beats. Its products include tachycardia implantab...
more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

St. Jude Medical (STJ) Shares Cross Below 200 DMA
Nasdaq - Dec 16, 2014
In trading on Tuesday, shares of St. Jude Medical, Inc. (Symbol: STJ) crossed below their 200 day moving average of $64.92, changing hands as low as $64.70 per share.
St. Jude Medicals Quadra Allure Pacemaker Gets CE Mark
Zacks.com - Dec 12, 2014
Global medical devices company, St. Jude Medical Inc. (STJ - Analyst Report), has announced the receipt of CE Mark for its Quadra Allure MP cardiac resynchronization therapy pacemaker (CRT-P).
St. Jude Medical receives CE Mark approval for Quadra Allure MP CRT-P - News-Medical.net
St. Jude Medical's Quadra Allure Pacemaker Gets CE Mark - Analyst Blog - Nasdaq
St. Jude Medicals CardioMEMS HF System Tests Positive
Zacks.com - Nov 19, 2014
St. Jude Medical Inc. (STJ - Analyst Report) has revealed a retrospective data analysis from its CHAMPION trial, conducted to evaluate the safety and efficacy of its CardioMEMS Heart Failure (HF) System on patients with New York Heart Association (NYHA ...
St. Jude Medical's CardioMEMS HF System Tests Positive - Analyst Blog - Nasdaq
Data Shows the CardioMEMS HF System Significantly Reduced 30-Day Hospital ... - MarketWatch
St. Jude Medical Price Target Increased to $74.00 by Analysts at Credit Suisse ...
WKRB News - Dec 15, 2014
Analysts at Cowen and Company upgraded shares of St. Jude Medical from a “market perform” rating to an “outperform” rating in a research note on Friday, November 21st.
St. Jude Medical Announces CE Mark Approval of the World's Only MultiPoint ...
Business Wire (press release) - Dec 11, 2014
ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced CE Mark approval of the Quadra Allure MP™ cardiac resynchronization therapy pacemaker (CRT-P). The Quadra Allure MP is the ...
Stock Insights on St. Jude Medical, Inc. (NYSE:STJ)
Markets Wired - Nov 19, 2014
[BUSINESS WIRE] St. Jude Medical, Inc. (NYSE:STJ) (Trend Analysis) a global medical device company, announced U.S.
Company Updates:St. Jude Medical , Audience Inc - Markets Insider
St. Jude Medical (STJ) Shares Cross Above 200 DMA
Nasdaq - Nov 21, 2014
In trading on Friday, shares of St. Jude Medical, Inc. (Symbol: STJ) crossed above their 200 day moving average of $64.81, changing hands as high as $66.13 per share.
St. Jude Medical Upgraded by Cowen and Company to “Outperform” (STJ) - WKRB News
St. Jude Medical Upgraded at Cowen and Company (STJ) - Watch List News (press release)
Form 4 ST JUDE MEDICAL INC For: Dec 14 Filed by: Murphy Mark W.
StreetInsider.com (subscription) - Dec 16, 2014
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). 1. Name and Address of Reporting Person *. Murphy Mark W. (Last), (First), (Middle). ONE ST. JUDE MEDICAL DRIVE. (Street). ST. PAUL, MN ...
St. Jude Medical Announces CE Mark Approval Of Quadra Allure MP CRT-P
RTT News - Dec 11, 2014
St. Jude Medical, Inc. (STJ: Quote), a medical device company, Thursday announced CE Mark approval of the Quadra Allure MP cardiac resynchronization therapy pacemaker or CRT-P.
Morningstar Issues "AA-" Credit Rating to St. Jude Medical (STJ)
sleekmoney - Dec 1, 2014
St. Jude Medical logo St. Jude Medical (NYSE:STJ) has been given an “AA-” credit rating by analysts at Morningstar.
Stocks Intraday Alert: St. Jude Medical, Inc. (NYSE:STJ), Delphi Automotive ... - Techsonian (press release)
Disclosure on Company Short Interest: St. Jude Medical , Idreamsky Technology ... - Markets Insider